×
For best experience we recommend to activate Javascript in your browser.
ARID3B antibody (AA 100-150)
The Rabbit Polyclonal anti-ARID3B antibody (ABIN7448418) specifically detects ARID3B in IHC.
The antibody is reactive with Human samples.
Catalog No. ABIN7448418
$532.77
Plus shipping costs $50.00
2.5 μg ABIN7464091
25 μg ABIN7448418
2.5 μg ABIN7464091
25 μg ABIN7448418
Delivery in 3 to 5 Business Days
Quick Overview for ARID3B antibody (AA 100-150) (ABIN7448418)
Target
See all ARID3B Antibodies
ARID3B
(AT Rich Interactive Domain 3B (BRIGHT-Like) (ARID3B))
Reactivity
All reactivities for ARID3B antibodies
Human
Host
All hosts for ARID3B antibodies
Rabbit
Clonality
All clonalities for ARID3B antibodies
Polyclonal
Conjugate
All conjugates for ARID3B antibodies
This ARID3B antibody is un-conjugated
Application
All applications for ARID3B antibodies
Immunohistochemistry (IHC)
Product Details anti-ARID3B Antibody
(hide)
Binding Specificity
All epitopes for ARID3B antibodies
AA 100-150
Purpose
Rabbit anti-ARID3B IHC Antibody, Affinity Purified
Predicted Reactivity
Orangutan,Monkey,Crab-eating macaque
Purification
Affinity Purified
Immunogen
Between AA 100 and 150
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
1:100 - 1:500
Restrictions
For Research Use only
Handling
(hide)
Concentration
250 μg/mL
Buffer
Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C
Expiry Date
12 months
Target Details for ARID3B
(hide)
Target
ARID3B
(AT Rich Interactive Domain 3B (BRIGHT-Like) (ARID3B))
Alternative Name
ARID3B
Background
Background: AT-rich interactive domain-containing protein 3B (ARID3B) is a transcription factor that may be involved in neuroblastoma growth and malignant transformation.
Gene ID
10620
UniProt
Q8IVW6
Recently viewed
(hide)
You are here:
Homepage
anti-ARID3B antibody (AA 100-150) (ABIN7448418)
Chat with us , powered by LiveChat